John E. Stelmach

Design and synthesis of potent, orally bioavailable dihydroquinazolinone inhibitors of p38 MAP kinase

John E. Stelmach, Luping Liu, Sangita B. Patel et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 81 citations · Full text

Medicinal Chemistry, P38 Map Kinase, Biochemistry +10

A highly stereoselective approach to the synthesis of the manzamine alkaloids via the intramolecular vinylogous amide photocycloaddition

Jeffrey D. Winkler, Miles G. Siegel, John E. Stelmach · Tetrahedron Letters · 1993 · 42 citations

Endogenous Retinoid X Receptors Can Function as Hormone Receptors in Pituitary Cells

Kelly Davis, Thomas J. Berrodin, John E. Stelmach et al. · Molecular and Cellular Biology · 1994 · 41 citations · Full text

Pituitary Cells, Retinoic Acid, Cell Proliferation +19

Two highly efficient syntheses of scalemic azocines

Jeffrey D. Winkler, John E. Stelmach, Jeffrey M. Axten · Tetrahedron Letters · 1996 · 39 citations · Full text

Bioorganic Chemistry, Engineering, Alkene Metathesis +11

p38MAP kinase inhibitors. part 1: design and development of a new class of potent and highly selective inhibitors based on 3,4-dihydropyrido[3,2-d]pyrimidone scaffold

S. Natarajan, David D. Wisnoski, Suresh B. Singh et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 36 citations · Full text

Medicinal Chemistry, Part 1, Biochemistry +13